rs746746116
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_006567.5(FARS2):c.925G>A(p.Gly309Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G309R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006567.5 missense
Scores
Clinical Significance
Conservation
Publications
- metabolic diseaseInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- combined oxidative phosphorylation defect type 14Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary spastic paraplegia 77Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006567.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FARS2 | NM_006567.5 | MANE Select | c.925G>A | p.Gly309Ser | missense | Exon 5 of 7 | NP_006558.1 | ||
| FARS2 | NM_001318872.2 | c.925G>A | p.Gly309Ser | missense | Exon 5 of 7 | NP_001305801.1 | |||
| FARS2 | NM_001374875.1 | c.925G>A | p.Gly309Ser | missense | Exon 5 of 7 | NP_001361804.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FARS2 | ENST00000274680.9 | TSL:1 MANE Select | c.925G>A | p.Gly309Ser | missense | Exon 5 of 7 | ENSP00000274680.4 | ||
| FARS2 | ENST00000324331.10 | TSL:1 | c.925G>A | p.Gly309Ser | missense | Exon 5 of 7 | ENSP00000316335.5 | ||
| FARS2 | ENST00000648580.1 | n.925G>A | non_coding_transcript_exon | Exon 5 of 9 | ENSP00000497889.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00 AC: 0AN: 250888 AF XY: 0.00
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461500Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727052 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 14 Pathogenic:3
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 309 of the FARS2 protein (p.Gly309Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with FARS2-related conditions (PMID: 28419689, 30177229). It has also been observed to segregate with disease in related individuals. This variant is also known as Gly273Ser. ClinVar contains an entry for this variant (Variation ID: 587672). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FARS2 protein function. Experimental studies have shown that this missense change affects FARS2 function (PMID: 28419689). For these reasons, this variant has been classified as Pathogenic.
The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.89; 3Cnet: 0.65). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000587672). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.
not provided Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at